Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
The company is progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102, targeting LRRK2 for neurodegenerative disorders; and ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma.
In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical stage PROTAC® androgen receptor protein degrader ARV-766 for the treatment of prostate cancer. The transaction closed in May 2024.
#TeamArvinas is made up of approximately 450 passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC® protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.
Position Summary
As a key member of our Commercial Leadership Team (CLT), the broader Arvinas Leadership Team (ALF) and Sales Leadership Team (SLT), the Vice President of Sales Oncology will play a critical role in shaping the launch strategy and execution plans for Arvinas’s inaugural commercial launch in oncology, focusing on our lead asset, vepdegestrant, in ER+, HER2- metastatic breast cancer.
This leadership position holds significant importance as it spearheads the establishment of Arvinas’s sales capabilities in oncology. Key responsibilities include actively contributing to the development of an executable brand strategy, recruiting top-tier sales leaders from the industry, and overseeing the recruitment, training, development, retention, and leadership of a sales team recognized as best in the industry by Healthcare Professionals (HCPs) and industry peers.
A pivotal aspect of the role is to lead with purpose, emphasizing a patient-focused, customer-focused, and people-focused approach. The Vice President of Sales will consistently align brand strategy with execution in a thoughtful and purposeful manner, aiming to achieve results that surpass conventional expectations.
This position reports to the Chief Commercial Officer and can be located at our headquarters in New Haven, CT or work remotely from a location within the U.S.
Key Responsibilities:
Qualifications:
Additional Qualifications:
#LI-Remote
Arvinas is proud to offer a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, and much more. To learn more about Arvinas, please visit www.arvinas.com
Arvinas is an Equal Opportunity Employer